Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors-Reference-Cited by-同舟云学术

Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors

Published:2023-06 Issue: Volume:192 Page:106782
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Ruffini Federica,Ceci Claudia,Atzori Maria Grazia,Caporali Simona,Levati Lauretta,Bonmassar Laura,Cappellini Gian Carlo Antonini,D’Atri Stefania,Graziani Grazia,Lacal Pedro Miguel

Funder

Ministero della Salute

Banca d'Italia

Associazione Italiana per la Ricerca sul Cancro

Regione Lazio

Publisher

Elsevier BV

Subject

Pharmacology

Reference64 articles.

1. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers;Roskoski;Pharmacol. Res.,2018

2. The future of targeted kinase inhibitors in melanoma;Caksa;Pharmacol. Ther.,2022

3. Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation;Sandri;Pharmacol. Res.,2016

4. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor;Caporali;Int. J. Oncol.,2016

5. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1;Ruffini;Oncotarget,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential;Biomedicine & Pharmacotherapy;2024-07

2. The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications;Pharmacological Research;2024-03